Patents (1436 Stem Cell Patents)

Uses of fibroblasts or supernatants from fibroblasts for the suppression of immune responses in transplantation

Patent Number: 7,491,388

Date of First Priority Issue: Friday November 13th, 1998
Date Issued: Tuesday February 17th, 2009
Assignee: Osiris Therapeutics, Inc. (Baltimore, MD)
Inventors: Mc Intosh; Kevin R. (Ellicott City, MD), Mosca; Joseph D. (Ellicott City, MD), Klyushnenkova; Elena N. (Baltimore, MD)

From Class: Use
Comments: No comments

We know that mesenchymal stem cells are immune modulatory through a variety of means such as secretion of HLA-G, expression of indolamine 2,3 deoxygenase, and production of immune suppressive cytokines.  What is relatively understudied is the immune regulatory activities of fibroblasts.  For example, Don Kleinsek, CEO, of GeriGene Medical Corporation has intellectual property covering various antiinflammatory and therapeutic uses of fibroblasts.

The current patent is based on in vitro mixed lymphocyte reaction data demonstrating suppressive activities of fibroblasts.  The inventors use this to cover:

1. A method of reducing an immune response against recipient tissue by donor tissue, comprising contacting the donor tissue with isolated fibroblasts in an amount effective to reduce an immune response by the donor tissue against the recipient; wherein the fibroblasts are allogeneic both to the donor and to the recipient of the donor tissue.

and

2. A method of reducing an immune response against recipient tissue by donor tissue, comprising contacting the donor tissue with isolated fibroblasts in an amount effective to reduce an immune response by the donor tissue against the recipient; wherein the donor tissue and the fibroblasts are contacted ex vivo prior to transplantation of the donor tissue; and wherein the donor tissue is exposed to recipient tissue prior to being contacted with the fibroblasts.

Note that what is being covered is immune response against the recipient, so obviously they are covering inhibition of graft versus host through modification of the graft by addition of fibroblasts, including third party, to the graft.

This work is an extension of the main Osiris program which is aimed at reduction of graft versus host disease through administration of third party mesenchymal stem cells obtained from the bone marrow, which the company has named Prochymal. 

View this patent on the USPTO website.

Added to StemCellPatents.com on Monday February 23rd, 2009

Social & Bookmarking:Digg 'Uses of fibroblasts or supernatants from fibroblasts for the suppression of immune responses in transplantation ' Add 'Uses of fibroblasts or supernatants from fibroblasts for the suppression of immune responses in transplantation ' to del.icio.us Add 'Uses of fibroblasts or supernatants from fibroblasts for the suppression of immune responses in transplantation ' to Technorati Stumble 'Uses of fibroblasts or supernatants from fibroblasts for the suppression of immune responses in transplantation ' Add 'Uses of fibroblasts or supernatants from fibroblasts for the suppression of immune responses in transplantation ' to Furl Add 'Uses of fibroblasts or supernatants from fibroblasts for the suppression of immune responses in transplantation ' to Reddit Add 'Uses of fibroblasts or supernatants from fibroblasts for the suppression of immune responses in transplantation ' to Blinklist Add 'Uses of fibroblasts or supernatants from fibroblasts for the suppression of immune responses in transplantation ' to Ma.gnolia Share 'Uses of fibroblasts or supernatants from fibroblasts for the suppression of immune responses in transplantation ' on Facebook Add 'Uses of fibroblasts or supernatants from fibroblasts for the suppression of immune responses in transplantation ' to Google Add 'Uses of fibroblasts or supernatants from fibroblasts for the suppression of immune responses in transplantation ' to Yahoo Web 

Add Comment

You must be signed-in to add your comments.

Sign-in now or Join the StemCellPatents.com Community for free.



Home | News | Patents | Products | Jobs | Links | Search | Journal | RSS

About | Advisory Board | Newsletter | Advertise | Contact | Sitemap | Privacy Policy | Terms of Use

Copyright © 2006 - 2024 StemCellPatents.com - All rights reserved. - Toronto Web Design

StemCellPatents.com V2.04

Stouffville Concrete | Tottenham Concrete | Uxbridge Concrete | Gerogetown Concrete | Rockwood Concrete | Kleinburg Concrete | Stouffville Real Estate Agent